Status:

COMPLETED

Study of the Follow-up of Stroke Treated With Anticoagulants

Lead Sponsor:

Centre Hospitalier Universitaire Dijon

Conditions:

Stroke

Eligibility:

All Genders

Brief Summary

Stroke is a major public health problem as it is very frequent (140,000 cases/year in France), and very serious (leading cause of death, 2nd leading cause of dementia, 3rd leading cause of handicap). ...

Eligibility Criteria

Inclusion

  • patients managed for stroke at the stroke unit of Dijon University Hospital for CAAF-related cardio-embolic stroke

Exclusion

  • NA

Key Trial Info

Start Date :

January 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2018

Estimated Enrollment :

441 Patients enrolled

Trial Details

Trial ID

NCT03292575

Start Date

January 1 2016

End Date

December 1 2018

Last Update

June 4 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU Dijon Bourgogne

Dijon, France, 21079

Study of the Follow-up of Stroke Treated With Anticoagulants | DecenTrialz